IL250115B
Anti-trem2 antibodies and methods of use thereof
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority and filed
- Published
- Today
Every citation, both ways
| Reference | Relation | Cited during |
|---|---|---|
| SUN M, ZHU M, CHEN K, NIE X, DENG Q, HAZLETT LD, WU Y, LI M, WU M, HUANG X., IMMUNOLOGY AND MICROBIOLOGY TREM-2 PROMOTES HOST RESISTANCE AGAINST PSEUDOMONAS AERUGINOSA INFECTION BY SUPPRESSING CORNEAL INFLAMMATION VIA A PL3K/AKT SIGNALING PATHWAY, 1 May 2013 (2013-05-01) | Non-patent | Search report |
| PENG Q, MALHOTRA S, TORCHIA JA, KERR WG, COGGESHALL KM, HUMPHREY MB., TREM2-AND DAP12-DEPENDENT ACTIVATION OF PI3K REQUIRES DAP10 AND IS INHIBITED BY SHIP1, 18 May 2010 (2010-05-18) | Non-patent | Search report |
| ITO H, HAMERMAN JA., TREM-2, TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELL?2, NEGATIVELY REGULATES TLR RESPONSES IN DENDRITIC CELLS, 28 September 2011 (2011-09-28) | Non-patent | Search report |
42 members in 13 offices
Members42
| Document | Office | Kind | |
|---|---|---|---|
| CA2955086A1 | Canada | A1 | |
| CA3090240A1 | Canada | A1 | |
| WO2016023019A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2016023019A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2015300787A1 | Australia | A1 | |
| IL250115A0 | Israel | A0 | |
| IL250115D0 | Israel | D0 | |
| SG11201700901SA | Singapore | A | |
| MX2017001531A | Mexico | A | |
| EP3177322A2 | European Patent Office (EPO) | A2 | |
| EA201790342A1 | Eurasian Patent Organization (EAPO) | A1 | |
| JP2017523814A | Japan | A | |
| US2017240631A1 | United States of America | A1 | |
| CN107106679A | China | A | |
| HK1243006A | Hong Kong, China | A | |
| HK1243006A1 | Hong Kong, China | A1 | |
| EP3177322A4 | European Patent Office (EPO) | A4 | |
| US2019010230A1 | United States of America | A1 | |
| US2019315858A1 | United States of America | A1 | |
| JP6669749B2 | Japan | B2 | |
| SG10201913611QA | Singapore | A | |
| JP2020063268A | Japan | A | |
| IL250115A | Israel | A | |
| IL250115BThis record | Israel | B | |
| IL279606A | Israel | A | |
| IL279606A | Israel | A | |
| IL279606D0 | Israel | D0 | |
| AU2021202840A1 | Australia | A1 | |
| US11084875B2 | United States of America | B2 | |
| JP2022081543A | Japan | A | |
| CN107106679B | China | B | |
| IL279606B | Israel | B | |
| EP4066859A1 | European Patent Office (EPO) | A1 | |
| MX2023000334A | Mexico | A | |
| MX2023000334A | Mexico | A | |
| US2023107639A1 | United States of America | A1 | |
| JP7326135B2 | Japan | B2 | |
| JP2024073453A | Japan | A | |
| NZ729157A | New Zealand | A | |
| NZ766877A | New Zealand | A | |
| AU2021202840B2 | Australia | B2 | |
| JP7730936B2 | Japan | B2 |
Numbers
- Publication
- 250115
- Application
- 25011517
Titles2
- English
- Anti-trem2 antibodies and methods of use thereof
- Hebrew
- נוגדנים אנטי–trem2 ושיטות לשימוש בהם
Classification
- CPC, 16
- C07K16/2803
- C07K16/28
- A61K2039/505
- C07K2317/21
- C07K2317/31
- C07K2317/33
- C07K2317/34
- C07K2317/55
- C07K2317/75
- C07K2317/76
- C07K2317/92
- A61P25/00
- A61P25/28
- C07K16/283
- C07K2317/52
- C07K2317/56